Toxicity of aromatase inhibitors may explain lack of overall survival improvement
Monday, August 22, 2011 - 16:00
in Health & Medicine
The toxicities associated with aromatase inhibitors (AIs) may explain the lack of overall survival improvement compared with tamoxifen, according to a study published August 22 in the Journal of The National Cancer Institute.